Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NEUmiRNA Therapeutics is a Danish pharmaceutical start-up based in Copenhagen, founded in 2020. The company focuses on achieving transformative disease modification for neurological conditions. Their lead program is an anti-miRNA treatment for patients with epilepsy. The company was co-founded by Dr. Henrik Klitgaard, a renowned figure in epilepsy research and drug development, and Professor Sakari Kauppinen, an expert in RNA/...
NEUmiRNA Therapeutics is a Danish pharmaceutical start-up based in Copenhagen, founded in 2020. The company focuses on achieving transformative disease modification for neurological conditions. Their lead program is an anti-miRNA treatment for patients with epilepsy. The company was co-founded by Dr. Henrik Klitgaard, a renowned figure in epilepsy research and drug development, and Professor Sakari Kauppinen, an expert in RNA/LNA-based therapies.

List your booth number for exhibitions, ask us